Comment on 'Adverse in-hospital outcomes in patients with paraplegia who undergo radical prostatectomy' [0.03%]
对“接受根治性前列腺切除术的截瘫患者住院不良结局”的评论
Longtu Ma,Rui Lu,Zhilong Dong
Longtu Ma
Reply to 'Comment on novel MRI-US fusion with advanced annotation in focal cryoablation for prostate cancer' [0.03%]
“前列腺癌焦点冷冻消融影像引导新技术的评论”答复文章
Alessandro Marquis,Ardeshir R Rastinehad
Alessandro Marquis
Comment on 'Novel MRI-US fusion with advanced annotation in focal cryoablation for prostate cancer: medium-term outcomes and learning curve insights' [0.03%]
关于“焦点冷冻消融治疗前列腺癌的新型MRI-US融合及先进标注：中期疗效和学习曲线启示”的评论
Longtu Ma,Rui Lu,Zhilong Dong
Longtu Ma
Response to: Bridging research and patient experience in chronic urinary tract infection [0.03%]
对“慢性泌尿系统感染的科研与患者体验相结合”的回应
Karin Andersen,Janni Søvsø Hjelmager,Thomas Emil Andersen et al.
Karin Andersen et al.
Prostate-specific antigen testing and prostate cancer-related outcomes: a Danish nationwide study [0.03%]
前列腺特异性抗原检测与前列腺癌预后的关系：一项丹麦全国性研究
Frederik K Palshof,Lina S Mørch,Klaus Brasso et al.
Frederik K Palshof et al.
Objective: To assess the prostate-specific antigen (PSA) testing and prostate cancer-related outcomes in a national, publicly funded healthcare setting, with recommendations against testing of asymptomatic men. ...
International Delphi consensus on feminising genital surgery in assigned-male-at-birth individuals [0.03%]
关于性别确认手术的国际德尔菲共识意见书
Marta Pezzoli,Mattia Lo Re,Valeria Pizziconi et al.
Marta Pezzoli et al.
Objective: To achieve an international expert consensus among surgeons on the indications, contraindications, and perioperative management of feminising genital surgery (FGS) for assigned-male-at-birth (AMAB) individuals,...
The nascent role of circulating tumour DNA in the management of non-muscle-invasive bladder cancer [0.03%]
循环肿瘤DNA在非肌层浸润性膀胱癌管理中的作用初探
Richard T Bryan,Keval Patel,Douglas G Ward
Richard T Bryan
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups [0.03%]
再次经尿道切除术对欧洲泌尿外科协会2021年各风险组高危T1期非肌层浸润性膀胱癌风险分层的影响
Ana Fernández-Mardomingo,Jose Daniel Subiela,Alberto Artiles Medina et al.
Ana Fernández-Mardomingo et al.
Objective: To evaluate the prognostic impact of T-stage at re-transurethral resection of bladder (TURB) and its utility for refining risk stratification across European Association of Urology 2021 (EAU21) risk groups in p...
Aligning bladder cancer research with patient needs: an update on research priorities [0.03%]
对接患者需求的膀胱癌研究动向——研究重点更新报告
Nada Humayun-Zakaria,Benjamin J Tura,Mieke van Hemelrijck et al.
Nada Humayun-Zakaria et al.
Artificial intelligence in urology training: practical benefits and real-world limits [0.03%]
人工智能在泌尿科培训中的实际效益与现实局限性
Stamatios Katsimperis,Ioannis Kyriazis,Panagiotis Neofytou et al.
Stamatios Katsimperis et al.